SEC Filing Summary: Platform Specialty Products Corporation
Business Context and Reporting Period
This Form 8-K, filed on November 2, 2017, by Platform Specialty Products Corporation (formerly Element Solutions Inc), reports the company's financial results for the three and nine months ended September 30, 2017. The filing serves to incorporate by reference a press release (Exhibit 99.1) detailing these results.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release containing these figures, including both GAAP and non-GAAP measures such as EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted earnings per share, and organic sales growth. The company also evaluates results on a constant currency basis.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the text provided. It notes that management uses non-GAAP measures to evaluate performance trends and isolate items with disproportionate impacts, but specific comparative data is contained in the attached press release.
Guidance, Outlook, and Risks
The filing mentions that the press release includes adjusted EBITDA guidance. Management commentary indicates that non-GAAP measures are used internally to assess absolute performance and trends. The filing includes standard disclaimers that non-GAAP measures are not substitutes for GAAP financial information and may differ from measures used by other companies. No specific risks or contingencies are detailed in the text of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, EBITDA, and earnings per share figures for the three and nine months ended September 30, 2017.
- Examine the reconciliation of non-GAAP measures to GAAP measures provided in the press release.
- Verify the specific adjusted EBITDA guidance for future periods mentioned in the press release.
- Confirm the impact of currency fluctuations on reported results as analyzed on a constant currency basis.